Article
BRCA2 gene mutations and coagulation-associated biomarkers.
Thrombosis and haemostasis - 1 Jan 2016
Perez-Segura Pedro, Zamorano-León José J, Acosta Daniel, Santos-Sancho Juana María, Modrego Javier, Caldés Trinidad, de la Hoya Miguel, Díaz-Rubio Eduardo, Díaz-Millán Isabel, de Las Heras Natalia, Rico Zalba Luis Alfonso, Lahera Vicente, Melander Olle, López Farré Antonio
Abstract excerpt
Thromboembolic events are the second cause of death in cancer patients, although the mechanisms underlying this increased thromboembolic risk remain unclear. The aims of this study were to examine whether BRCA2 gene mutations may modify the circulating levels of thrombocoagulation biomarkers and whether breast cancer development may influence changes in such circulating biomarkers. The study was performed in 25...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.